Business UpdateAug 3, 2026, 08:11 AM
Pomdoctor Details Four-Tier Diversified Revenue Structure
AI Summary
POMDOCTOR Limited detailed its four-tier diversified revenue structure, aiming to leverage established B2C healthcare operations with new technology-enabled services. The company reported net revenues of RMB399.9 million (US$59.04 million) in fiscal year 2025 from its B2C segment. The strategy includes AI-enabled chronic disease membership subscriptions, B2B enterprise and hospital services, and pharmaceutical RWS/RWD services to drive recurring revenue and long-term value.
Key Highlights
- Highlights a four-tier diversified revenue structure combining established healthcare with technology-enabled services.
- B2C basic healthcare services generated net revenues of RMB399.9 million (US$59.04 million) in FY2025.
- FY2024 net revenues were RMB342.6 million, and FY2023 net revenues were RMB304.9 million.
- Developing AI-enabled chronic disease membership subscriptions for recurring revenue and higher margins.
- Expanding B2B enterprise and hospital services for institutional commercialization.
- Developing pharmaceutical real-world study (RWS) and real-world data (RWD) services as a long-term value driver.
Price Impact
More from POM